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In previous studies, we showed that peptidoglycan polysaccharides from anaerobic bacteria normally present
in the human gut induced severe chronic joint inflammation in rats. Our hypothesis is that peptidoglycan from
the gut flora is involved in perpetuation of idiopathic inflammation. However, in the literature, the presence of
peptidoglycan or subunits like muramyl peptides in blood or tissues is still a matter of debate. We were able
to stain red pulp macrophages in all six available human spleens by immunohistochemical techniques using
a monoclonal antibody against gut flora-derived antigens. Therefore, these human spleens were extracted, and
after removal of most of the protein, the carbohydrate fraction was investigated for the presence of muramic
acid, an amino sugar characteristic for peptidoglycan. Using three different methods for detection of muramic
acid, we found a mean of 3.3 mmol of muramic acid with high-pressure liquid chromatography, 1.9 mmol with
a colorimetric method for detection of lactate, and 0.8 mmol with an enzymatic method for detection of D-lactate
per spleen (D-lactate is a specific group of the muramic acid molecule). It is concluded that peptidoglycan is
present in human spleen not as small muramyl peptides as were previously searched for by other investigators
but as larger macromolecules probably stored in spleen macrophages.
Muramic acid (Mur) is one of the two amino sugars in the
glycan backbone of peptidoglycan (murein). It is mostly
present in an acetylated form, i.e., N-acetylmuramic acid. Short
peptides are linked to the lactyl groups of this molecule, form-
ing a large complex macromolecule which surrounds the cell as
a basket around the cell membrane (29). In this study, Mur was
used as a chemical marker for peptidoglycan polymers. Sen
and Karnovsky (20) showed the qualitative detection of mu-
ramic acid in normal mammalian tissues. Fox and Fox (5) were
not able to detect Mur in normal serum, which demonstrates
the absence of appreciable amounts of circulating natural mu-
ramyl peptides. Our group is interested in the presence of
peptidoglycan in tissues, as we believe that such intestinal flora
derived carbohydrates are important for physiological and im-
munological functions in the host. Johannsen et al. (11, 12)
showed that muramyl peptides have a variety of biological
actions in mammals, including the ability to enhance sleep and
body temperature. In the last 15 years, many authors have
described biological activities of peptidoglycan in vivo and in
vitro, all indicating that peptidoglycan can influence cells like
lymphocytes and macrophages which are involved in inflam-
mation. Lichtman et al. (15) showed that livers of rats injected
intraperitoneally with peptidoglycan were able to reactivate
arthritis after transplantation into a second rat with preinjured
joints. They postulate that peptidoglycan present in the liver is
redistributed to other tissues, including the injured joints,
where it causes reactivation of arthritis. From the studies done
by Lichtman et al., it seemed obvious to look for large bacterial
fragments in human tissues. Our group is investigating the
relationship between arthritis and intestinal bacteria (9). By
using a rat model, the arthropathic properties of cell wall
fragments of a number of obligate anaerobic bacteria belong-
ing to the major residents of the intestinal flora were described
(14, 21–23). Recently, we developed a monoclonal antibody
against a bacterial flora-derived peptidoglycan polysaccharide
fraction from human feces and found positive staining of rat
spleen macrophages (13). Therefore, we have strong support
for the presence of bacterial flora-derived products in the
spleen. In this study, we analyzed six surgically removed human
spleens. Using colorimetric Mur analysis, enzymatic determi-
nation of D-lactic acid, and high-pressure liquid chromatogra-
phy (HPLC) analysis, we demonstrated the presence of sub-
stantial amounts of Mur. We concluded that peptidoglycan
polymers are present in human spleen.
MATERIALS AND METHODS
Spleen. Six sterile unfixed human spleens were obtained from the pathology
department immediately after surgery (SSDZ, Delft, The Netherlands) and kept
frozen until use. The spleen was removed from each of five patients (patients 1
through 5) with gastric adenocarcinomas for technical reasons and from patient
6 because of traumatic rupture. Spleen samples were aerobically and anaerobi-
cally cultured on blood agar base during 48 h at 378C. No bacterial growth was
observed. The anaerobic plates were cultured in a jar supplied with GasPak
generator envelopes with palladium catalyst (Becton Dickinson).
Immunological staining. Immunohistologic staining of the human spleen was
performed according by the method of Kool et al. used for the staining of rat
spleen (13). The same monoclonal antibody, 2E9 (mouse immunoglobulin G3),
recognizing intestinal flora derived peptidoglycan polysaccharides was used.
Staining was also performed with 2-4, a monoclonal antibody recognizing mu-
ramyl dipeptide as described by Bahr et al. (1).
Spleen extraction. For spleen extraction (Fig. 1), 50 to 100 g of minced spleen
in 500 to 1,000 ml of H2O was homogenized in portions by a Virtis homogenizer
(Virtis Company) at 10,000 rpm for 30 s. The homogenate was sonicated five
times for 1 min each at maximum amplitude (MSE Soniprep 150). Acetic acid
(96%) was added to a final concentration of 0.2 M. The extract was incubated at
room temperature for 2 h under rotation and was subsequently heated gradually
in a water bath to 1008C over a period of 30 min. The extract was centrifuged at
10,000 3 g. The volume of the supernatant was reduced by lyophilization to 25
to 50 ml, and the extract was then centrifuged at 100,000 3 g. The supernatants
(15-ml portions) were separated by gel filtration on a 275-ml gel bed of Sephadex
G-25 (Pharmacia, Uppsala, Sweden). Mur and protein were determined in all
fractions by the methods of Hadzija (7) and Bradford (2). The high-molecular-
weight fraction was collected and loaded onto a Dowex 50W34 column (Fluka
Chemie AG, Buchs, Switzerland) equilibrated in 0.1 M acetic buffer (pH 4.6) for
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further protein reduction. The volume of the pooled fractions was reduced by
lyophilization to 10 ml, and this preparation was dialyzed against 1 dm3 of 1 M
NaCl and thereafter three times against 3 dm3 of H2O (bidest). After centrifu-
gation at 100,000 3 g, the supernatant was stored and used for determination of
Mur (see below). This preparation is further referred to as A. For HPLC analysis
of Mur, a further removal of protein was necessary. Therefore, a DEAE–Sepha-
rose CL-6B (Pharmacia) gel bed of 22 ml was washed with 0.5 M NaCl followed
by a large volume of H2O. Then 5 ml of preparation A was loaded onto the
column and eluted with H2O until no more protein was detected. A 15-ml
Mur-containing fraction was collected after elution with 0.5 M NaCl. This 15-ml
sample was dialyzed against H2O, lyophilized, and dissolved in 2 ml of H2O. This
preparation is further referred to as B. In preparation B Mur, protein and total
carbohydrates (17) were determined.
Determination of Mur. (i) Preparation A.Mur was determined by the method
of Hadzija (7), with some modifications (8). In short, samples were hydrolyzed by
heating for 2 h at 908C with an equal volume of 5 M H2SO4 and then neutralized
with 10 M NaOH. Hydrolyzed and unhydrolyzed samples (100 ml) were incu-
bated with 50 ml of 1 M NaOH at 368C for 30 min. After the addition of 1 ml of
18.8 M H2SO4 (concentrated), samples were heated for 3.5 min at 1008C, rapidly
cooled in ice, and then mixed with 10 ml of 0.16 M CuSO45 z H2O in H2O and 20
ml of 0.09 M p-hydroxydiphenyl in ethanol. The blue color developed to a
maximum in 30 min at 308C. A570 was determined with a Titertek Multiskan
(Flow Laboratories, Irvine, Scotland). Solutions containing 0 to 100 mg of Mur
(Sigma, St. Louis, Mo.) per ml of H2O were used as standards. The data are given
as the difference in concentration between the hydrolyzed and nonhydrolyzed
samples. In this way, only Mur linked to the peptides in peptidoglycan is deter-
mined, and disturbing sugars like rhamnose and of course of lactic acid itself,
which are determined in the nonhydrolyzed sample, can be excluded. The pres-
ence of Mur in preparation A was also determined by measurement of D-lactic
acid by the method of Tipper (26). Two milliliters of preparation A was hydro-
lyzed with 2 ml of 12 M HCl at 908C for 2 h. The sample was lyophilized and
dissolved in 1 ml of H2O. D-Lactate was determined by enzymatic bioanalysis of
D-lactic acid–L-lactic acid (Boehringer Mannheim GmbH, Mannheim, Germany).
(ii) Preparation B. The presence of Mur was determined with an amino acid
amino sugar determination using reverse-phase HPLC techniques as described
by Glauner (6). In short, for dansylation of preparation B, 1 ml was hydrolyzed
with 500 ml of 12 M HCl for 3 h at 908C. The sample was frozen, lyophilized, and
redissolved in 100 ml of H2O. This sample was added to 100 ml of 200 mM borate
buffer (pH 8.8) and 100 ml of 20 mM dansyl chloride (5-dimethylamino-naph-
thalene-1-sulfonyl chloride; Fluka) in acetone and allowed to react for 2 h at
378C. The reaction was stopped with 200 mM phosphoric acid. Valine was used
as an internal standard, and all other standard amino acids (Sigma) underwent
the same treatment.
Separation of dansylated amino acids and amino sugars was accomplished by
reverse-phase HPLC. Samples were analyzed with a Pharmacia-LAB 2248 single-
pump solvent delivery system and VWM 2141 UV-VIS monitor both connected
to a computer working with HPLC Manager software to control the pump,
gradient mixer, and UV-VIS detector operating at 330 nm. Integration and
analysis of chromatograms was performed with the same software (Pharmacia).
Dansylated samples were separated on a Pharmacia SuperPac Sephasil C18
column (5 mm, 4 by 250 mm). The flow rate used was 1 ml/min, and the buffers
used were A (20 mM sodium phosphate [pH 5.25]) and B (60% acetonitrile, 40%
50 mM sodium phosphate [pH 4.0]). At 0, 10, 16, 21.5, 22, and 27 min, the
percentages of preparation B were 30, 50, 100, 100, 30, and 30, respectively.
Eluted products were detected at 330 nm, the wavelength which is maximally
absorbed by the dansyl groups. Internal standard valine and external standards
valine and Mur were used for calculating Mur contents of the spleen samples.
RESULTS
Immunohistochemistry of the spleen. Red pulp macro-
phages in the six spleens were immunohistochemically stained.
Figure 2 shows an immunohistologic staining of a human
spleen with monoclonal antibody 2E9 recognizing intestinal
FIG. 1. Flow diagram of the extraction and purification of a Mur-containing fraction from human spleen.
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flora-derived peptidoglycan polysaccharides. Monoclonal anti-
body 2-4, recognizing muramyl dipeptide, also stained cells in
these spleens (not shown). Negative control antibody NS7 of
the same isotype, mouse immunoglobulin G3, and with irrele-
vant specificity did not stain the spleens. From these positive
results, we concluded that bacterial antigens were present in
each of the spleens and that these could be used for isolation
of a particular bacterial fraction.
Purification of Mur fraction from spleen. From all six
spleens, preparation A was isolated as described above. The
general outlines of the procedure are depicted in Fig. 1. Figure
3 shows the elution pattern after Sephadex G-25 gel filtration
of the extracted spleen from patient 1. Protein was found after
an elution volume of 95 ml of H2O. Mur was detected after an
elution volume of 85 ml of H2O and increased to a maximum
of 32 mg of Mur per ml. Then it decreased and finally sharply
increased to a level much higher than 100 mg/ml. We pooled
the fractions between 85 and 130 ml, which represented a
relatively high-molecular-weight fraction, and discarded the
low-molecular-weight fraction because it contained lactate,
which disturbed the colorimetric Mur assay. The pool was
loaded on a strong cation-exchange column, Dowex 50W34,
which bound 90% of the protein. After this step, the volume
was reduced and the preparation was dialyzed. In a pilot ex-
periment, samples of lysozyme-solubilized cell wall fragments
of Eubacterium aerofaciens (22), a carbohydrate polymer with
FIG. 2. Immunohistologic staining with monoclonal 2E9 of human spleen. Three large 2E9-positive macrophages are stained black. Bar, 21.8 mm.
FIG. 3. Separation of high- and low-molecular-weight fractions by Sephadex G-25 gel filtration of an extract of human spleen of patient 1. In step 5 in Fig. 1, 15
ml of spleen extract was loaded onto a 275-ml gel bed of a Sephadex G-25 column, and Mur and protein concentrations were determined in the fractions.
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20% (dry weight) Mur, were completely recovered in the cor-
responding fractions after the Sephadex G-25 gel filtration and
for 80% after the Dowex chromatography.
From all spleens, 10 ml of preparation A was prepared. In
preparation A, the protein concentration was still 0.5 to 1.5
mg/ml. The concentration Mur was determined by the method
of Hadzija (7) with and without hydrolysis of the samples, and
the net values are given in Table 1. Mur was also determined
by using D-lactic acid dehydrogenase as described by Tipper
(26). Table 1 shows that in all preparations, the concentrations
determined with the colorimetric method were higher than
those found with the enzymatic method. Using E. aerofaciens
cell wall fragments, we found twice as much Mur with the
colorimetric method as with the enzymatic method of Tipper.
Because both determinations of Mur are based on the pres-
ence of the lactyl group in Mur, we felt that a completely
different assay for Mur should be used to confirm the results.
Therefore, HPLC analysis of Mur was used. Since the method
is based on a separation of dansylated amino acids and amino
sugars, the preparation must be as free as possible from dis-
turbing protein amino acids. Therefore, the remains of prep-
aration A from spleens 1 to 5 were further purified by DEAE
anion-exchange chromatography. The E. aerofaciens cell wall
polymers applied to the DEAE column showed that the pro-
tein part of the preparation was not bound. The Mur-contain-
ing fraction, however, did bind and could be eluted from the
column with 0.5 M NaCl. DEAE passage of preparation A
reduced the protein contents considerably (,200 mg/ml). In
this sample, called preparation B, Mur, protein, and total car-
bohydrate concentrations were determined with colorimetric
assays, and the results are shown in Table 2.
Samples of preparation B of spleens 1 to 5 were applied to
HPLC. The strategy that we used for Mur detection by HPLC
was as follows. First, by adding a little dansylated muramic acid
to the sample, it was possible to spike a peak with a retention
time of 11.3 min in the spleen sample, as depicted in Fig. 4A
and B. There are many peaks in the chromatogram, and there-
fore we decided to collect the peak with retention time 11.3
min and reanalyze this peak to see if it really has the same
retention time as the standard dansyl Mur. Indeed, a major
peak of the chromatogram of the collected peak had exactly
the same retention time as dansyl Mur (Fig. 4C and D). Fi-
nally, we determined Mur in the collected peak by using the
colorimetric assay of Hadzija to complete the circle and prove
that the spleen samples contain Mur.
Calculations of Mur concentration by using valine as an
internal standard gave results in the same range as the other
method but may have been hampered by contaminating pro-
tein amino acids (Table 2). When the results of Mur concen-
trations (Tables 1 and 2) are summarized as mean values, then
with HPLC 3.3 mmol, with the Hadzija method 1.9 mmol (prep-
aration B) and 2.4 mmol (preparation A), and with the Tipper
method 0.8 mmol per spleen (average, 73 g) were found.
DISCUSSION
Sen and Karnovsky found 100 pmol of Mur per g of rat liver
tissue and extracted muramyl compounds from brain and kid-
ney (20). A daily output of 1 mmol of free diaminopimelic acid,
an amino acid specific for muramyl peptides, was found in
human urine by Johannsen and Krueger (10). Fox and Fox,
however, could not detect Mur in human serum and therefore
considered the presence of peptidoglycan- or Mur-containing
subunits a matter of dispute (5). In this study, we determined
Mur in spleen tissue by three different methods. The spleen
was chosen because a previous immunohistochemical study
with monoclonal antibodies showed the presence of bacterial
antigen in macrophages in the rat spleen (13). The six human
spleens used in this study also contained macrophages posi-
tively stained by monoclonal antibody 2E9. Specificity of the
monoclonal antibody was checked by inhibition enzyme-linked
immunosorbent assays and by inhibition of immunohistologic
staining of the spleens. Peptidoglycan polysaccharides were
used as antigens.
The isolation procedure was focused on detecting Mur in
polymeric peptidoglycan because that is the product which we
think is present in the splenic macrophages, given our obser-
vations in rats injected with peptidoglycan polysaccharides
from E. aerofaciens (13). Small muramyl dipeptide adminis-
tered in vivo in mice, however, is excreted unchanged in the
urine within minutes (27). The practical advantage of this as-
sumption is that during the extraction and purification, the
low-molecular-weight fraction could be discarded. In this re-
spect, our study differed from the studies of Sen and Karnosky
(20), who were looking for low-molecular-weight muropep-
tides. Before and after homogenization of the spleen tissues,
sterility was checked by cultivating the homogenate on a blood
agar plate. No contamination could be detected. Acetic acid
extraction was used to hydrolyze the lysosomes in the spleen
homogenates in which the peptidoglycan might be located
(19). After this, the aim was to remove as much protein as
possible while keeping the carbohydrate fraction. In the end,
we succeeded in isolating such a fraction containing a consid-
erable amount of Mur. Mur was used as a marker for the
presence of polymers of peptidoglycan because Mur is consid-
ered to be unique for peptidoglycan.
We used three determination methods for Mur. (i) The
method of Hadzija (7) (modified by Hazenberg et al. [8]) is
based on the colorimetric determination of the lactyl group
after acid hydrolyzes to remove peptides in peptidoglycan and
treatment with NaOH to hydrolyze the ether bond of the lactyl
group in Mur.
(ii) The method of Tipper (26) was also used. D-Lactic acid
TABLE 1. Recovered Mur determined according to Hadzija
(modified) and Tipper methods in preparation A from six human
spleen extractions
Spleen Spleen wet wt(g)
Mur (mmol) as determined
by the method of:
Hadzija Tipper
1 91 2.82 0.97
2 70 2.27 0.75
3 55 2.29 0.38
4 93 2.66 0.40
5 57 1.79 0.43
6 73 2.56 2.04
TABLE 2. Mur, protein, and total carbohydrates in preparation B
from five human spleen extractions
Spleen
Mur (mM)
Protein
(mg/ml)
Carbohydrates
(mg/ml)Hadzija
method HPLC
1 2.64 5.28 564 3,320
2 1.40 3.56 352 2,000
3 1.04 2.16 412 2,000
4 3.60 4.40 368 5,080
5 0.76 1.32 780 1,240
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is specific for bacteria (24), and the covalent ether bond of
D-lactic acid in Mur is very specific for this molecule and
therefore for peptidoglycan. We adopted the method of Tip-
per, in which lactate dehydrogenase is used for the detection of
D-lactic acid in peptidoglycan liberated after acid and alkali
hydrolysis. Indeed, D-lactate was found in our E. aerofaciens
cell wall fragment preparation after consecutive acid and al-
kalic hydrolysis (data not shown).
(iii) Because both methods for determination of Mur are
based on detection of the (D) lactyl group, a third method not
dependent on the presence of lactic acid was used. The HPLC
analysis of amino sugars was carried out by a modified proce-
dure developed by Glauner (6), who studied the composition
of peptidoglycan of Escherichia coli extensively. After collec-
tion of the peaks with a retention time of 11.3 min (Fig. 4), we
were able to determine Mur in this fraction with the Hadzija
method. We conclude that in the human spleen Mur and
therefore peptidoglycan is present not as small muramyl pep-
tides as were previously looked for but as larger molecules
probably stored in spleen macrophages.
Peptidoglycan has many biological effects in vivo; they in-
clude sleep induction (16), complement activation (30), adju-
vant activity (4), and many other immunostimulatory effects
such as antibody production (28) and T-cell-mediated arthritis
induction (9, 14, 21–23). In vitro peptidoglycans are able to
stimulate human monocytes to produce tumor necrosis factor
alpha and interleukin-1 and inhibition or activation of mono-
cyte migration (18, 25). From the results presented in this
report and results from other investigators, it can be concluded
that our body tissues are continuously exposed to these bacte-
rial products which in some cases might lead to biological
activities in vivo. If so, this in its turn might provide a clue to
inflammation with unknown etiology, such as rheumatoid ar-
thritis and reactive arthritis. Presently we are investigating the
biological properties of this peptidoglycan.
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